Eric L Grogan

14PUBLICATIONS

70CO-AUTHORS

Predictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 23, 2026

Longitudinal analysis of CYFRA 21-1 levels in patients with pulmonary nodules: Differential trajectories between benign and malignant cases.

|Jun 10, 2026

Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules.

|Jun 03, 2026

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

|Feb 06, 2026

Longitudinal Analysis of CYFRA 21-1 Levels in Patients with Pulmonary Nodules: Differential Trajectories Between Benign and Malignant Cases and Impact of Tumor Resection.

Yency J Forero, Michael N Kammer, Kevin C McGann

|Sep 15, 2025

Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet?

Kevin C McGann, Timothy A Khalil, Michael N Kammer

|Mar 12, 2025

Optimizing Biomarker Models for Biologically Heterogeneous Cancers: A Nested Model Approach for Lung Cancer.

Palina Woodhouse, Laurel Jackson, Michael N Kammer

Pageof 3

Frequent Collaborators

Steve A Deppen

Michael N Kammer

Fabien Maldonado

Bennett Landman

Yency J Forero

Xiao-Ou Shu

Kevin C McGann

Sheau-Chiann Chen

Palina Woodhouse

Kevin Connor McGann

Frequent Collaborators

Steve A Deppen

Michael N Kammer

Fabien Maldonado

Bennett Landman